State NJ
Clinical Trials in New Jersey
Recruiting clinical trials with at least one study location in New Jersey. Data updated daily from ClinicalTrials.gov.
Top Conditions in New Jersey
NCT06813911 Phase 3
Recruiting
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Partic...
Condition
Atherosclerotic Cardiovascular Disease (ASCVD)
Enrollment
340 pts
Location
United States, China, France
Sponsor
Novartis Pharmaceuticals
NCT03587844 Phase 2
Recruiting
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
Condition
Mycosis Fungoides
Enrollment
58 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT07037433 Phase 3
Recruiting
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in P...
Condition
Atherosclerotic Cardiovascular Disease
Enrollment
12,800 pts
Location
United States, Argentina, Australia
Sponsor
Amgen
NCT05836324 Phase 1
Recruiting
A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Met...
Condition
Solid Tumors
Enrollment
408 pts
Location
United States, Denmark, France
Sponsor
Incyte Corporation
NCT04097145 N/A
Recruiting
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
Condition
Tricuspid Regurgitation
Enrollment
870 pts
Location
United States, Canada
Sponsor
Edwards Lifesciences
NCT06440473 Phase 4
Recruiting
Visualization of Topical Zoryve vs. Vehicle Using Line Field Optical Coherence T...
Condition
Healthy Skin
Enrollment
3 pts
Location
United States
Sponsor
Rao Dermatology
NCT06872905 N/A
Recruiting
Real-World Data Collection of the GORE® VIABAHN® VBX Balloon Expandable Endopros...
Condition
Aortoiliac Occlusive Disease
Enrollment
158 pts
Location
United States, Italy, Netherlands
Sponsor
W.L.Gore & Associates
NCT06797219 N/A
Recruiting
Light Therapy Device for Neonatal Intraventricular Hemorrhage Grade 3 and 4
Condition
Intraventricular Hemorrhage of Prematurity
Enrollment
24 pts
Location
United States
Sponsor
Rutgers, The State University
NCT06801067 Phase 1
Recruiting
A Study of SER-155 to Treat Diarrhea in People on Immunotherapy
Condition
Diarrhea
Enrollment
15 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT07225946 Phase 3
Recruiting
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metas...
Condition
Prostatic Neoplasms, Castration-Resistant
Enrollment
800 pts
Location
United States, Australia, Brazil
Sponsor
Janssen Research & Development
NCT05546580 Phase 1
Recruiting
Study of Iadademstat and Gilteritinib in Patients With R/R AML With FMS-like Tyr...
Condition
Acute Myeloid Leukemia, in Relapse
Enrollment
50 pts
Location
United States
Sponsor
Oryzon Genomics S.A.
NCT06037941 N/A
Recruiting
Using E-Nose Technology to Measure Response to Treatment in People With Malignan...
Condition
Malignant Pleural Mesothelioma
Enrollment
20 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
NCT06925737 Phase 3
Recruiting
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Pros...
Condition
Prostate Cancer
Enrollment
1,440 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT05327686 Phase 2
Recruiting
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for t...
Condition
Metastatic Renal Cell Carcinoma
Enrollment
240 pts
Location
United States, Australia, Canada
Sponsor
NRG Oncology
NCT06889831 N/A
Recruiting
WORTH Paths Intervention
Condition
Substance Use Disorder (SUD)
Enrollment
50 pts
Location
United States
Sponsor
Fairleigh Dickinson University
NCT06941272 Phase 1, Phase 2
Recruiting
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refr...
Condition
Malignant Neoplasm
Enrollment
50 pts
Location
United States, Australia, Belgium
Sponsor
Merck Sharp & Dohme LLC
NCT06384261 Phase 2
Recruiting
A Study Comparing Venetoclax and Azacitidine Plus Cusatuzumab to Venetoclax and ...
Condition
Leukemia, Myeloid, Acute
Enrollment
120 pts
Location
United States, Canada, Germany
Sponsor
OncoVerity, Inc.
NCT07214961 Phase 1
Recruiting
Study of Alpha Radioligand Therapy AB001 in Patients With Metastatic Castration ...
Condition
Prostate Cancer (CRPC)
Enrollment
80 pts
Location
United States
Sponsor
ARTBIO Inc.
NCT04462770 Phase 3
Recruiting
A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrom...
Condition
Dravet Syndrome
Enrollment
150 pts
Location
United States, Canada, Georgia
Sponsor
Epygenix
NCT05894239 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Ph...
Condition
Metastatic Breast Cancer
Enrollment
230 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
NCT04300556 Phase 1, Phase 2
Recruiting
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein ...
Condition
Solid Tumor
Enrollment
182 pts
Location
United States, France, Japan
Sponsor
Eisai Inc.
NCT07104383 Phase 3
Recruiting
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)
Condition
Weight Loss
Enrollment
1,100 pts
Location
United States, Puerto Rico
Sponsor
Viking Therapeutics, Inc.
NCT06650202 N/A
Recruiting
Improving Balance After Spinal Cord Injury Using a Robotic Upright Stand Trainer...
Condition
SCI - Spinal Cord Injury
Enrollment
20 pts
Location
United States
Sponsor
Kessler Foundation
NCT06741527 N/A
Recruiting
Integrity Implant System Post Market Clinical Follow-Up Study
Condition
Rotator Cuff Tears of the Shoulder
Enrollment
150 pts
Location
United States
Sponsor
Anika Therapeutics, Inc.
NCT06136650 Phase 3
Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Age...
Condition
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Enrollment
1,314 pts
Location
United States, Australia, Brazil
Sponsor
Merck Sharp & Dohme LLC